Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Protein Trafficking ER Proteins

Recombinant Human EPM2AIP1 protein (ab127387)

Key features and details

  • Expression system: Escherichia coli
  • Tags: His tag N-Terminus
  • Suitable for: SDS-PAGE

You may also be interested in

Product image
Recombinant Human ERp72 protein (His tag) (ab276531)
Product image
Anti-SEC61B antibody (ab192329)
Product image
Anti-SRP54 antibody [EPR10851(B)] (ab154796)
Product image
Anti-LRMP antibody [EPR17852] (ab202418)

Description

  • Product name

    Recombinant Human EPM2AIP1 protein
  • Expression system

    Escherichia coli
  • Accession

    Q7L775
  • Protein length

    Protein fragment
  • Animal free

    No
  • Nature

    Recombinant
    • Species

      Human
    • Predicted molecular weight

      17 kDa
    • Amino acids

      438 to 579
    • Tags

      His tag N-Terminus

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at -20ºC.

    Constituents: 0.32% Tris HCl, 0.58% Sodium chloride

  • Reconstitution
    Reconstitute with water to desired concentration

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.